4-methoxyamphetamine has been researched along with spironolactone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagardi, M; Brambilla, PG; Galizzi, A; Locatelli, C; Malchiodi, D; Zanaboni, A | 1 |
| Chambers, H; Fonfara, S; Laskary, A; O'Sullivan, ML | 1 |
1 trial(s) available for 4-methoxyamphetamine and spironolactone
| Article | Year |
|---|---|
Prospective clinical trial evaluating spironolactone in Doberman pinschers with congestive heart failure due to dilated cardiomyopathy.
Topics: Animals; Atrial Fibrillation; Cardiomyopathy, Dilated; Death; Dog Diseases; Dogs; Euthanasia, Animal; Heart Failure; Prospective Studies; Spironolactone | 2022 |
1 other study(ies) available for 4-methoxyamphetamine and spironolactone
| Article | Year |
|---|---|
Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cohort Studies; Death; Dog Diseases; Dogs; Female; Furosemide; Male; Mitral Valve Insufficiency; Multivariate Analysis; Pyridazines; Retrospective Studies; Spironolactone; Survival Analysis | 2021 |